Etrasimod Interactions

Brand names: Velsipity

2 interactions on record

Etrasimod + FluconazoleModerate

Moderate to Strong Inhibitors of CYP2C9 and CYP3A4 Clinical Impact Increased exposure of etrasimod was observed with concomitant use with a drug that is a moderate inhibitor of CYP2C9 and a moderate inhibitor of CYP3A4 (i.e., fluconazole) [see Clinical Pharmacology (12.3) ] .

Source: FDA drug label - etrasimod

Etrasimod + ProcainamideUnknown

Prevention or Management Seek the advice of a cardiologist before initiating VELSIPITY treatment with Class Ia (e.g., quinidine, procainamide), Class III anti-arrhythmic drugs (e.g., amiodarone, sotalol), or other drugs that prolong the QT interval.

Source: FDA drug label - etrasimod